DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar SnoopyDancing (< 20) Submitted: 12/29/2008 4:01:03 PM : Outperform Start Price: $3.19 DRRX Score: -124.56

Awesome ability to take old drugs and make them more safe. Doctors already know the older drugs, so making them even safer makes sales easier and helps minimize potential drug interactions.

Featured Broker Partners


Advertisement